HOUSTON (Dec. 17, 2013) OrthoAccel® Technologies, Inc. announces two new additions to its senior management team, Jeff Layton as the company’s new chief operations officer and Doug Bukaty as vice president of sales. Both executives have distinguished careers that include management positions at Fortune 500 companies.
As chief operations officer, Layton oversees OrthoAccel’s product engineering, design, development and manufacturing as well as supply chain, quality assurance and customer service. Most recently he was the vice president of operations for Xtreme Power, a manufacturer of renewable energy storage systems. Layton’s 25-year career also includes management positions at Dell, where he was the director of power and reliability engineering, and at 3M, where he was the plant engineering operations manager for the company’s dental products division. A graduate of the U.S. Naval Academy, Layton was a nuclear submarine engineering operations officer in the United States Navy.
As the leader of OrthoAccel’s sales division, Bukaty oversees all aspects of business development and revenue growth. He comes to the company from Sarnova, a private, equity-backed specialty medical distribution business where he served as vice president of sales for Bound Tree Medical. Bukaty has more than a decade of corporate experience in the orthodontic industry with past sales positions at Align Technology and Johnson & Johnson’s “A” Company Orthodontics. A graduate of the University of Kansas, Bukaty also completed professional development programs at Northwestern University’s Kellogg School of Management.
“Jeff Layton and Doug Bukaty are great additions to OrthoAccel’s senior management team and we know that their strong records of success in operations and sales will help fuel our next level of growth as the leader in accelerated orthodontics,” said Mike Lowe, president and CEO of OrthoAccel Technologies, Inc. OrthoAccel manufactures AcceleDent, the only FDA-cleared, Class II medical device that has been proven to accelerate orthodontic treatment up to 50 percent.
Lowe adds, “These executives join OrthoAccel at a time of tremendous momentum as our AcceleDent product is now offered in over 1,000 orthodontic offices in North America with plenty of opportunity for continued growth.” Orthodontists and staff members who are interested in learning more about AcceleDent, or how to offer the technology at their practice, can locate an OrthoAccel sales representative at AcceleDent.com/orthodontists or by calling 866-866-4919.
About OrthoAccel® Technologies, Inc.
Based in Houston, Texas, OrthoAccel® Technologies, Inc. is a privately owned medical device company engaged in the development, manufacturing and marketing of products to enhance dental care and orthodontic treatment. OrthoAccel developed and sells AcceleDent® Aura, the first FDA-cleared clinical approach to safely accelerate orthodontic tooth movement by applying gentle micropulses via SoftPulse Technology® as a complement to existing orthodontic treatment. More information can be found at www.acceledent.com and www.acceledent.co.uk or requested via email@example.com.